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Abstract
Genetic factors play an important role in determining the risk of multiple sclerosis (MS). The strongest genetic association in
MS is located within the major histocompatibility complex class II region (MHC), but more than 50 MS loci of modest effect
located outside the MHC have now been identified. However, the relative candidate genes that underlie these associations
and their functions are largely unknown. We conducted a protein-protein interaction (PPI) analysis of gene products coded
in loci recently reported to be MS associated at the genome-wide significance level and in loci suggestive of MS association.
Our aim was to identify which suggestive regions are more likely to be truly associated, which genes are mostly implicated
in the PPI network and their expression profile. From three recent independent association studies, SNPs were considered
and divided into significant and suggestive depending on the strength of the statistical association. Using the Disease
Association Protein-Protein Link Evaluator tool we found that direct interactions among genetic products were significantly
higher than expected by chance when considering both significant regions alone (p,0.0002) and significant plus
suggestive (p,0.007). The number of genes involved in the network was 43. Of these, 23 were located within suggestive
regions and many of them directly interacted with proteins coded within significant regions. These included genes such as
SYK, IL-6, CSF2RB, FCLR3, EIF4EBP2 and CHST12. Using the gene portal BioGPS, we tested the expression of these genes in 24
different tissues and found the highest values among immune-related cells as compared to non-immune tissues (p,0.001).
A gene ontology analysis confirmed the immune-related functions of these genes. In conclusion, loci currently suggestive of
MS association interact with and have similar expression profiles and function as those significantly associated, highlighting
the fact that more common variants remain to be found to be associated to MS.
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Introduction
Multiple Sclerosis (MS) is the most common inflammatory
disease of central nervous system (CNS) which affects young adults
[1]. It is widely acknowledged that genetic factors play an
important role in determining the risk of MS [2]. Several
epidemiological studies demonstrated an increased frequency of
MS among biological relatives of affected individuals [3,4]. Family
based and association studies have shown that the strongest genetic
association in MS is located within the major histocompatibility
complex (MHC) class II region [5]. In particular the HLA-
DRB1*1501 allele confers an approximate odds ratio of 3 [6].
However, during the last few years Genome Wide Association
Studies (GWAS) have identified many other MS associated loci of
modest effect located outside the MHC (now more than 50) [7–
11].
Despite the recent advances in the understanding of the genetic
architecture of MS, several questions remain to be answered. For
example, due to stringent correction criteria many genetic variants
fail to reach genome-wide significance but can still be considered
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as suggestive of genetic association. Furthermore, once a SNP is
found to be associated with a particular disease, the relative
candidate gene (or genes) that mediate such association is usually
unknown.
Analysis of protein-protein interaction (PPI) networks is being
increasingly recognized as an important tool to characterize the
underlying biology of genes associated to complex diseases, in
particular immune-mediated ones [12,13]. It is logical to
hypothesize that those genes which are truly associated with the
same trait will be involved in similar biological processes. For
example, Rossin et al. found that proteins encoded in genomic
regions associated to rheumatoid Arthritis and Crohn’s disease
physically interact more than what would be expected by chance
and that the genes encoding these proteins are highly expressed in
immune tissues [12]. Studying such PPI interactions can ultimately
elucidate which suggestive regions are more likely to be truly
associated and greatly aid the identification of those genes that are
mediating the GWAS findings.
We conducted a PPI analysis of gene products coded in loci
recently reported to be MS associated and suggestive of MS
association. Our aim was to identify which suggestive regions are
more likely to be truly associated, which genes are mostly
implicated in the MS PPI network, their expression profiles and
functions.
Methods
Three recent independent association studies were considered
for our analysis [14–16]. In Sawcer et al. and Patsopoulos et al.,
SNPs were divided into significant and suggestive depending on
the strength of the statistical association [14,15]. From Sawcer et al
we defined as suggestive those SNPs with p values in the discovery
phase of less than 161024 and significant those that either were
replication of previous GWAS findings or had a replication
p,0.05 and a p-combined,561027 [14]. In Patsopoulos et al.,
significant SNPs were defined as either those with p-val-
ue,561028 or replication of previously identified associated
SNPs. Suggestive SNPs were those with p-values between 561028
and 161026 [15]. We also included in the analyses the top 82
SNPs (with a log p value.4.91) from Wang et al [16]. All SNPs
from this study were considered as suggestive, because the study
was not designed to meet currently accepted criteria for genome
wide significance. After removing duplicate SNPs, 67 significant
and 133 suggestive SNPs were obtained.
Protein-to-protein interaction assessment was conducted using
the Disease Association Protein-Protein Link Evaluator (DAPPLE)
tool [12]. This bioinformatics tool is able to investigate physical
interactions among gene products encoded within certain genomic
regions by the creation of a PPI network. Interactions are
extracted from the database ‘‘InWeb’’ that combines data from a
variety of public PPI sources including MINT, BIND, IntAct and
KEGG and defines high confidence interactions as those seen in
multiple independent experiments. The region around a given
SNP is extended to the genomic interval defined by SNPs in
moderate linkage disequilibrium (r‘2.=0.5) and then to the
nearest recombination hotspots [12]. Connections can be direct
(two proteins are physically linked to each other) and indirect
(interaction is mediated by a common interactor). The extent of
the PPI network are assessed using the following parameters: the
number of direct interactions between proteins from different loci,
the mean associated protein direct and indirect connectivities (the
mean number of distinct loci a protein is directly or indirectly
connected to) and the mean common interactor connectivity
(average number of proteins in separate loci bound by common
interactors) [12]. The non-randomness of the network and the
significance of the interaction parameters are tested using a
permutation method that compares the original network with
thousands of networks created by randomly re-assigning the
protein names while keeping the overall structure (size and
number of interactions) of the original network. Those genes that
participate in the network more than expected by chance are
defined as genes to prioritize (corrected p,0.05) [12]. Expression
data were gathered from BioGPS, an online gene annotation
database that reports individual gene expression levels for a
number of human tissues and cell types [17]. Analyses were
performed using non-parametric tests (Kruskal-Wallis and Mann-
Whitney tests). Gene ontology terms were investigated using The
Database for Annotation, Visualization and Integrated Discovery
(DAVID) v6.7, an online tool that is able to identify the functional
categories and biological processes which are most represented
within a list of genes [18,19].
Results
Dapple analysis of significant SNPs
Our first aim was to assess the extent of PPI interactions among
genes located within genomic regions with definite association with
MS susceptibility. We therefore submitted into DAPPLE the 67
SNPs with genome-wide significant association with MS risk.
There were a total of 75 proteins participating in the direct
network with 104 direct interactions (expected direct interac-
tions = 61, p,0.0002) (Table 1, Figure 1 and Table S1). The mean
associated protein direct connectivity was 2.7 (expected = 1.7,
p,0.0002). The mean associated protein indirect connectivity was
52.2 (expected = 43.8, p = 0.04) and the mean common interactor
connectivity was 4.5. (expected = 3.9, p = 0.0002). The total
number of genes implicated in the network was 215 (Table S1).
The total number of genes that had more connections than
expected by chance (genes to prioritize) was 22 and included
previously shown putative candidate genes such as IL-12A, SOCS-
1, CBLB, MALT-1, IL-22RA, MAPK-1 and IL-7R.
Dapple analysis of significant plus suggestive SNPs
When suggestive SNPs were included in the analysis, the
number of proteins participating in the network and that of direct
interactions increased from 75 to 189 and from 104 to 281
respectively (expected direct interactions = 242, p,0.007) (Table 1,
Figure 2 and Table S2). The mean associated protein direct
connectivity was also higher than expected (observed= 2.9,
expected = 2.4, p = 0.0008). The mean associated protein indirect
connectivity was 93 (expected = 91, p = 0.34). The mean common
interactor connectivity was 5.05 (expected= 4.8, p = 0.05). The
total number of genes analyzed was 445 (Table S2), while genes to
prioritize were 43 of which 23 were located within suggestive
regions. These included genes such as SYK, IL-6, CSF2RB, FCLR3,
EIF4EBP2 and CHST12 (Table 2).
Tissue-specific expression and gene ontology terms of
candidate genes
In order to further investigate the nature of our findings we
assessed in which tissues these genes were mostly expressed. We
used the gene portal BioGPS which contains gene expression data
on a variety of human tissues and cell types [17]. For our analysis
we considered 10 immune cell types and 14 non-immune tissues.
We submitted the full list of candidate genes (n = 43) obtained
from the significant plus suggestive DAPPLE analysis and for each
gene we obtained a different genetic expression value in every
tissue or cell type tested. Because of different background
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Figure 1. Direct connections among gene products from MS significant regions. Colours indicate significance of participation in the PPI
network.
doi:10.1371/journal.pone.0046730.g001
Table 1. Summary of DAPPLE analysis of significant and significant plus suggestive SNPs.
Significant Significance
Significant +
suggestive Significance
Number of proteins in the network 75 - 189 -
Direct interactions 104 p,0.0002 281 p,0.007
MAPDC* 2.7 p,0.0002 2.9 p= 0.0008
MAPIC** 52.2 p= 0.04 93 p= 0.34
Mean CI connectivity*** 4.5 p= 0.0002 5.05 p= 0.05
Genes to prioritize 39 - 22 -
*Mean associated protein direct connectivity;
**Mean associated protein indirect connectivity;
***Mean Common Interactor connectivity.
doi:10.1371/journal.pone.0046730.t001
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characteristics between each probe set, a direct comparison of
expression across different genes was not possible. Therefore, we
decided to standardize the expression values of each single gene
across different tissues and used the obtained z-values for all
subsequent analyses. Figure 3 shows the standardized expression
values in the 24 tissues and cell types tested. Expression appeared
particularly high in whole blood as well as in most of immune-
related cell types (in particular B-cells, plasmacytoid dendritic cells
(pDCs), natural killer (NK) cells, CD4+ and CD8+ T cells). An
independent-sample Kruskal-Wallis test confirmed that gene
expression was significantly different across tissues (p,0.001).
When tissues were divided into immune and non-immune,
expression was substantially different between the two groups
(p,0.001) (Figure 4). When compared to average expression across
tissues, candidate genes were significantly overexpressed in B-
lymphoblasts, pDCs, monocytes, B cells, NK cells, CD4+ T cells
(p,0.001), CD34+ hematopoietic cells (p = 0.001) and CD8+ T
cells (p = 0.003). Expression patterns were similar for significantly
and suggestively associated loci.
We further confirmed the immunological nature of these
candidate genes using DAVID [18,19], a bioinformatics tool that
is able to identify the biological processes in which a group of
genes are involved. Candidate genes were significantly enriched
for immune related processes such as regulation of leukocyte
activation (p = 3.1061028), regulation of T cell proliferation
(p = 3.2561028), positive regulation of immune system processes
(p = 7.761027), regulation of protein kinase cascade
(p = 5.4661024) and regulation of cytokine production
(p = 0.001459) (see Table S3 for the full list). GO enrichment
was similar for significantly and suggestively associated loci.
Discussion
We showed that genetic products coded in loci strongly
associated with MS risk substantially interact with each other.
Both direct and indirect interactions were significantly higher than
what would be expected by chance only. When the PPI analysis
was extended to suggestive SNPs, we found an increased number
of total proteins participating in the network and direct
Figure 2. Direct connections among gene products from MS significant plus suggestive regions. Colours indicate significance of
participation in the PPI network.
doi:10.1371/journal.pone.0046730.g002
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interactions (Figure 1 and 2). The only parameter that did not
reach significance was the number of indirect interactions. This
finding could be explained by the possible lack of real MS
association among several suggestive SNPs.
However, including suggestive SNPs in the PPI analysis
increased the number of genes to prioritize from 22 to 43.
Interestingly, more than half of these genes (n = 23) were located
within suggestive regions and many of them directly interacted
with proteins coded within significant regions (e.g. CSF2RB-CBLB,
IL6-IL2RA, MAPK3K14-NFKB1, SYK-STAT3, see Table S2).
Taken together the suggestive statistical evidence of genetic
association and the functional evidence of protein-protein
interaction support the hypothesis that these genes could play an
important role in the pathogenesis of MS.
We validated our results looking at tissue specific expression of
these candidate genes. Using the BioGPS database we were able to
show that the suggestively associated genes identified by DAPPLE
were largely and specifically expressed in immune cells as
compared to other tissues. A gene ontology analysis also confirmed
the immune-related functions of these genes. More generally, these
findings provide additional support to the immunological nature of
MS [20]. Notably, candidate gene expression was particularly high
among CD8+ and CD4+ T cells, B cells, NK cells and pDCs.
Interestingly all these cell types have been implicated in the
pathogenesis of MS.
Several immune specific genes are located within MS suggestive
regions. For example a SNP located near the gene encoding the
Spleen Tyrosine Kinase (SYK) was found suggestive of association
in Sawcer et al. Notably SYK was particularly highly expressed in
B-cells, DCs, monocytes, CD33+ myeloid cells and NK cells. This
protein has a central role in adaptive immune receptor signalling
by phosphorylation of the immunoreceptor tyrosine-based activa-
tion motifs (ITAMs) [21]. SYK mediated ITAMs phosphorylation
determines activation of signalling intermediates such as NF-kB,
JNK and PYK2 that ultimately lead to lymphocyte activation [22].
ITAM signals mediated by SYK can also induce expansion of NK
cells [23]. Interestingly, the SYK-inhibitor R788 (fostamatinib) has
beneficial effects in patients affected by RA, when compared to
placebo [24].
CSF2RB is another gene particularly highly expressed in B-cells,
DCs, monocytes, CD33+ myeloid cells and NK cells. It codes for
the b-subunit (bc) of the granulocyte-macrophage colony-stimu-
lating factor (GM-CSF), IL-3 and IL-5 receptors that are
expressed by peripheral leucocytes and blood DCs [25]. This
gene appears to play an important role in allergic inflammation
[26]. Interestingly, associations between CSF2RB and schizophre-
nia [27] and bipolar disorder [28] have been recently found.
EIF4EBP2 encodes the Eukaryotic Translation Initiation Factor
4E Binding Protein 2. The members of this family of proteins
(4EBPs) can inhibit translation initiation through binding eIF4E
[29]. 4EBPs regulate cell proliferation by interaction with
mTORC1 pathway [30]. In addiction, EIF4EBP1 knock-out mice
showed a type I IFN over production in pDCs [31]. We found an
over-expression of EIF4BP2 in pDCs, CD4 cells, CD8 cells and
Table 2. List of candidate genes (genes to prioritize) obtained from DAPPLE analysis of significant plus suggestive SNPs.
SIGNIFICANT SUGGESTIVE
GENE SNP STUDY GENE SNP STUDY
BCL9L rs630923 14 ARAP3 rs2302103 14
CARD11 rs11581062 14 CHST12 rs6952809 14
CBLB rs2028597 14 CSF2RB rs2072711 14
IL12A rs2243123 14 FCRL3 rs3761959 14
IL12B rs2546890 14,15 MAP3K14 rs4792814 14
IL20RA rs17066096 14 NDFIP1 rs1062158 14
IL22RA2 rs17066096 14 SLC30A7 rs12048904 14
IL2RA rs3118470 14 SYK rs290986 14
IL7R rs6897932 14,15 UBASH3B rs7941030 14
MALT1 rs7238078 14 IQCB1 rs2681424 15
MAPK1 rs2283792 14 ANGPT2 rs2515585 16
RPS25 rs630923 14 C12orf51 rs11065987 16
SOCS1 rs7200786 14 CDH2 rs528438 16
SP110 rs10201872 14 CUX2 rs11065987 16
SP140 rs10201872 14 EIF4EBP2 rs10762363 16
STAT3 rs9891119 14 ENSG00000205175 rs1611715 16
TMEM87B rs17174870 14 ENSG00000204600 rs434496 16
TYK2 rs8112449 14 ENSG00000205173 rs434446 16
YPEL2 rs180515 14 IL6 rs10244467 16
C12orf65 rs1790100 15 RBM45 rs10203141 16
SLC30A6 rs13029809 16
TRAFD1 rs11065987 16
Wdr23(DCAF11) rs10146906 16
doi:10.1371/journal.pone.0046730.t002
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Figure 3. Expression values of candidate genes (genes to prioritize) in all 23 tissues and cell types tested.
doi:10.1371/journal.pone.0046730.g003
Figure 4. Expression values of candidate genes (genes to prioritize) in immune and non immune tissues.
doi:10.1371/journal.pone.0046730.g004
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NK cells. CHST12 encodes the carbohydrate (chondroitin 4-O)
sulfotransferase 2, a protein located in the membrane of the Golgi
apparatus membrane and which is implicated in chondroitin and
dermatan sulphate (DS) synthesis in different tissues [32]. DS
proteoglycans participate in various biological events such as
extracellular matrix assembly, cell adhesion, migration and
proliferation [33]. We found high expression of CHST12 in pDCs,
CD4 cells, CD8 cells and NK cells.
To conclude, a number of proteins coded by genes located
within MS-associated genomic regions are implicated in the same
PPI networks. The extent of this interaction substantially increases
when genomic regions with suggestive evidence of association are
included in the analysis. This suggests that at least some of these
suggestive GWAS hits represent truly associated loci, and thus
more common variants remain to be found to be associated to MS.
Finally, we further confirmed the immunological nature of MS
and show how a single cell type cannot explain the complexity
of this disease. Future functional studies should investigate how
and in which cell types the suggestive candidate genes are
acting. This will improve our knowledge of this complex disease
and hopefully provide future strategies of disease prevention and
treatment.
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